Review



counterstain nuclei  (Vector Laboratories)


Bioz Verified Symbol Vector Laboratories is a verified supplier
Bioz Manufacturer Symbol Vector Laboratories manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 98

    Structured Review

    Vector Laboratories counterstain nuclei
    Counterstain Nuclei, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 98/100, based on 21320 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/counterstain nuclei/product/Vector Laboratories
    Average 98 stars, based on 21320 article reviews
    counterstain nuclei - by Bioz Stars, 2026-05
    98/100 stars

    Images



    Similar Products

    98
    Vector Laboratories counterstain nuclei
    Counterstain Nuclei, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/counterstain nuclei/product/Vector Laboratories
    Average 98 stars, based on 1 article reviews
    counterstain nuclei - by Bioz Stars, 2026-05
    98/100 stars
      Buy from Supplier

    99
    Beyotime counterstaining nuclei with dapi
    Exploration of the anti-inflammatory and antioxidant mechanisms of GA@LDs-CRAMP in BMDMs . A) Immunofluorescence images of Nrf2 (red) and nuclei (blue) in LPS-stimulated BMDMs. Scale bar: 10 μm. B) Quantitative analysis of the Pearson colocalization coefficient between Nrf2 red fluorescence and <t>DAPI-stained</t> nuclear blue fluorescence (n = 5). C) Western blot validation and semiquantitative analysis of macrophage polarization markers (iNOS, Arg1) and inflammatory cytokines (IL-6). D) Western blot validation and semiquantitative analysis of relative expression of NF-κB pathway components (p65, p-p65, IκBα, p-IκBα) (n = 3). E) Western blot validation and semiquantitative analysis of relative expression of Nrf2 pathway components (Nrf2, Keap1, HO-1, NQO1) (n = 3). ns > 0.05, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
    Counterstaining Nuclei With Dapi, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/counterstaining nuclei with dapi/product/Beyotime
    Average 99 stars, based on 1 article reviews
    counterstaining nuclei with dapi - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc counterstaining nuclei
    Exploration of the anti-inflammatory and antioxidant mechanisms of GA@LDs-CRAMP in BMDMs . A) Immunofluorescence images of Nrf2 (red) and nuclei (blue) in LPS-stimulated BMDMs. Scale bar: 10 μm. B) Quantitative analysis of the Pearson colocalization coefficient between Nrf2 red fluorescence and <t>DAPI-stained</t> nuclear blue fluorescence (n = 5). C) Western blot validation and semiquantitative analysis of macrophage polarization markers (iNOS, Arg1) and inflammatory cytokines (IL-6). D) Western blot validation and semiquantitative analysis of relative expression of NF-κB pathway components (p65, p-p65, IκBα, p-IκBα) (n = 3). E) Western blot validation and semiquantitative analysis of relative expression of Nrf2 pathway components (Nrf2, Keap1, HO-1, NQO1) (n = 3). ns > 0.05, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
    Counterstaining Nuclei, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/counterstaining nuclei/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    counterstaining nuclei - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    96
    Vector Laboratories counterstain 145 nuclei
    Exploration of the anti-inflammatory and antioxidant mechanisms of GA@LDs-CRAMP in BMDMs . A) Immunofluorescence images of Nrf2 (red) and nuclei (blue) in LPS-stimulated BMDMs. Scale bar: 10 μm. B) Quantitative analysis of the Pearson colocalization coefficient between Nrf2 red fluorescence and <t>DAPI-stained</t> nuclear blue fluorescence (n = 5). C) Western blot validation and semiquantitative analysis of macrophage polarization markers (iNOS, Arg1) and inflammatory cytokines (IL-6). D) Western blot validation and semiquantitative analysis of relative expression of NF-κB pathway components (p65, p-p65, IκBα, p-IκBα) (n = 3). E) Western blot validation and semiquantitative analysis of relative expression of Nrf2 pathway components (Nrf2, Keap1, HO-1, NQO1) (n = 3). ns > 0.05, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
    Counterstain 145 Nuclei, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/counterstain 145 nuclei/product/Vector Laboratories
    Average 96 stars, based on 1 article reviews
    counterstain 145 nuclei - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    90
    Carl Roth GmbH cell nuclei counterstain
    Exploration of the anti-inflammatory and antioxidant mechanisms of GA@LDs-CRAMP in BMDMs . A) Immunofluorescence images of Nrf2 (red) and nuclei (blue) in LPS-stimulated BMDMs. Scale bar: 10 μm. B) Quantitative analysis of the Pearson colocalization coefficient between Nrf2 red fluorescence and <t>DAPI-stained</t> nuclear blue fluorescence (n = 5). C) Western blot validation and semiquantitative analysis of macrophage polarization markers (iNOS, Arg1) and inflammatory cytokines (IL-6). D) Western blot validation and semiquantitative analysis of relative expression of NF-κB pathway components (p65, p-p65, IκBα, p-IκBα) (n = 3). E) Western blot validation and semiquantitative analysis of relative expression of Nrf2 pathway components (Nrf2, Keap1, HO-1, NQO1) (n = 3). ns > 0.05, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
    Cell Nuclei Counterstain, supplied by Carl Roth GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cell nuclei counterstain/product/Carl Roth GmbH
    Average 90 stars, based on 1 article reviews
    cell nuclei counterstain - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    99
    Thermo Fisher nuclei counterstaining with hoechst
    VEGFR2 and VEGF are expressed in the same NSCs. a Kdr and Vegfa in situ hybridization co-labeled with GFAP antibody in adult mouse DG. Scale bar represents 10 µm. b Percent of putative RGL-NSCs that are Kdr + , Vegfa + , or Kdr + / Vegfa + by in situ hybridization coupled with immunolabeling for GFAP. N = 4 mice; mean ± SEM. c Representative immunofluorescent image of VEGFR2 immunolabeling with Nestin in a VEGF-GFP mouse. Arrowheads show VEGFR2 + /VEGFGFP + /Nestin + co-expression. Scale bar represents 20 µm. d Representative 3D renderings of z-stack images of VEGFA and VEGFR2 immunoreactivity in the ER (PDI) or Golgi (RCAS1, Syntaxin) in permeabilized cultured NSCs. <t>Hoechst</t> labels nuclei. Major lines in image boxes are 10 µm apart
    Nuclei Counterstaining With Hoechst, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nuclei counterstaining with hoechst/product/Thermo Fisher
    Average 99 stars, based on 1 article reviews
    nuclei counterstaining with hoechst - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    96
    Vector Laboratories nuclei counterstaining
    VEGFR2 and VEGF are expressed in the same NSCs. a Kdr and Vegfa in situ hybridization co-labeled with GFAP antibody in adult mouse DG. Scale bar represents 10 µm. b Percent of putative RGL-NSCs that are Kdr + , Vegfa + , or Kdr + / Vegfa + by in situ hybridization coupled with immunolabeling for GFAP. N = 4 mice; mean ± SEM. c Representative immunofluorescent image of VEGFR2 immunolabeling with Nestin in a VEGF-GFP mouse. Arrowheads show VEGFR2 + /VEGFGFP + /Nestin + co-expression. Scale bar represents 20 µm. d Representative 3D renderings of z-stack images of VEGFA and VEGFR2 immunoreactivity in the ER (PDI) or Golgi (RCAS1, Syntaxin) in permeabilized cultured NSCs. <t>Hoechst</t> labels nuclei. Major lines in image boxes are 10 µm apart
    Nuclei Counterstaining, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nuclei counterstaining/product/Vector Laboratories
    Average 96 stars, based on 1 article reviews
    nuclei counterstaining - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    Image Search Results


    Exploration of the anti-inflammatory and antioxidant mechanisms of GA@LDs-CRAMP in BMDMs . A) Immunofluorescence images of Nrf2 (red) and nuclei (blue) in LPS-stimulated BMDMs. Scale bar: 10 μm. B) Quantitative analysis of the Pearson colocalization coefficient between Nrf2 red fluorescence and DAPI-stained nuclear blue fluorescence (n = 5). C) Western blot validation and semiquantitative analysis of macrophage polarization markers (iNOS, Arg1) and inflammatory cytokines (IL-6). D) Western blot validation and semiquantitative analysis of relative expression of NF-κB pathway components (p65, p-p65, IκBα, p-IκBα) (n = 3). E) Western blot validation and semiquantitative analysis of relative expression of Nrf2 pathway components (Nrf2, Keap1, HO-1, NQO1) (n = 3). ns > 0.05, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

    Journal: Materials Today Bio

    Article Title: Bioinspired lipid droplets nanoplatform for periodontitis therapy: Integrated antibacterial, mitochondrial repair, and immunomodulatory functions

    doi: 10.1016/j.mtbio.2026.102808

    Figure Lengend Snippet: Exploration of the anti-inflammatory and antioxidant mechanisms of GA@LDs-CRAMP in BMDMs . A) Immunofluorescence images of Nrf2 (red) and nuclei (blue) in LPS-stimulated BMDMs. Scale bar: 10 μm. B) Quantitative analysis of the Pearson colocalization coefficient between Nrf2 red fluorescence and DAPI-stained nuclear blue fluorescence (n = 5). C) Western blot validation and semiquantitative analysis of macrophage polarization markers (iNOS, Arg1) and inflammatory cytokines (IL-6). D) Western blot validation and semiquantitative analysis of relative expression of NF-κB pathway components (p65, p-p65, IκBα, p-IκBα) (n = 3). E) Western blot validation and semiquantitative analysis of relative expression of Nrf2 pathway components (Nrf2, Keap1, HO-1, NQO1) (n = 3). ns > 0.05, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

    Article Snippet: Synthesis conditions were screened by staining LDs with BODIPY 493/503 (5 μM, MedChemExpress, USA) and counterstaining nuclei with DAPI (7 μM, Beyotime, China).

    Techniques: Immunofluorescence, Fluorescence, Staining, Western Blot, Biomarker Discovery, Expressing

    VEGFR2 and VEGF are expressed in the same NSCs. a Kdr and Vegfa in situ hybridization co-labeled with GFAP antibody in adult mouse DG. Scale bar represents 10 µm. b Percent of putative RGL-NSCs that are Kdr + , Vegfa + , or Kdr + / Vegfa + by in situ hybridization coupled with immunolabeling for GFAP. N = 4 mice; mean ± SEM. c Representative immunofluorescent image of VEGFR2 immunolabeling with Nestin in a VEGF-GFP mouse. Arrowheads show VEGFR2 + /VEGFGFP + /Nestin + co-expression. Scale bar represents 20 µm. d Representative 3D renderings of z-stack images of VEGFA and VEGFR2 immunoreactivity in the ER (PDI) or Golgi (RCAS1, Syntaxin) in permeabilized cultured NSCs. Hoechst labels nuclei. Major lines in image boxes are 10 µm apart

    Journal: Molecular Neurobiology

    Article Title: Intracrine VEGF Signaling Is Required for Adult Hippocampal Neural Stem Cell Maintenance and Vascular Proximity

    doi: 10.1007/s12035-025-04861-1

    Figure Lengend Snippet: VEGFR2 and VEGF are expressed in the same NSCs. a Kdr and Vegfa in situ hybridization co-labeled with GFAP antibody in adult mouse DG. Scale bar represents 10 µm. b Percent of putative RGL-NSCs that are Kdr + , Vegfa + , or Kdr + / Vegfa + by in situ hybridization coupled with immunolabeling for GFAP. N = 4 mice; mean ± SEM. c Representative immunofluorescent image of VEGFR2 immunolabeling with Nestin in a VEGF-GFP mouse. Arrowheads show VEGFR2 + /VEGFGFP + /Nestin + co-expression. Scale bar represents 20 µm. d Representative 3D renderings of z-stack images of VEGFA and VEGFR2 immunoreactivity in the ER (PDI) or Golgi (RCAS1, Syntaxin) in permeabilized cultured NSCs. Hoechst labels nuclei. Major lines in image boxes are 10 µm apart

    Article Snippet: The following day, after three rinses in PBS, cells were incubated in secondary antibodies diluted in blocking solution for 2 h. If a biotinylated secondary was used, a fluorophore-conjugated tertiary was applied for 1 h diluted in PBS before rinsing and nuclei counterstaining with Hoechst (10 min, 1:2000 in PBS) (Invitrogen).

    Techniques: In Situ Hybridization, Labeling, Immunolabeling, Expressing, Cell Culture

    Cell autonomous VEGF signaling maintains NSCs in culture. a Diagram of the neighbor rescue experiment. b , c VEGF concentration (pg/ml) in NSC conditioned media after treatment with high MOI ( b ) or low MOI ( c ) mCherry or mCherryCre lentivirus. N = 3 wells/grp; mean ± SEM plus individual wells shown. d Representative immunofluorescent images of BrdU + cultured Vegfa lox/lox and WT NSCs (Hoechst + ) after lentiviral infection (mCherry + ). Chevrons indicate BrdU + mCherry + Hoechst + NSCs. e Percent of mCherry + or mCherry − Vegfa lox/lox and WT NSCs that were BrdU + after low MOI mCherryCre and mCherryonly lentiviral infection. N = 3/grp/exp, 3 exps. Mean ± SEM shown. f Representative images of cultured Vegfa lox/lox NSCs (brightfield) after lentiviral infection (mCherry + ) after 1 and 4 passages. Images taken immediately after passage, when counting was performed. g Representative images of cultured WT NSCs (brightfield) after lentiviral infection (mCherry + ) after 1 and 4 passages. Images taken immediately after passage, when counting was performed. h Percent of mCherry + Vegfa lox/lox and WT NSCs after infection with low MOI mCherryCre or mCherryonly lentiviral vectors. N = 3/grp/exp, 2 exps; mean ± SEM. Scale bars represent d 10 µm and f , g 50 µm. * p < 0.05; ** p < 0.01; **** p < 0.0001

    Journal: Molecular Neurobiology

    Article Title: Intracrine VEGF Signaling Is Required for Adult Hippocampal Neural Stem Cell Maintenance and Vascular Proximity

    doi: 10.1007/s12035-025-04861-1

    Figure Lengend Snippet: Cell autonomous VEGF signaling maintains NSCs in culture. a Diagram of the neighbor rescue experiment. b , c VEGF concentration (pg/ml) in NSC conditioned media after treatment with high MOI ( b ) or low MOI ( c ) mCherry or mCherryCre lentivirus. N = 3 wells/grp; mean ± SEM plus individual wells shown. d Representative immunofluorescent images of BrdU + cultured Vegfa lox/lox and WT NSCs (Hoechst + ) after lentiviral infection (mCherry + ). Chevrons indicate BrdU + mCherry + Hoechst + NSCs. e Percent of mCherry + or mCherry − Vegfa lox/lox and WT NSCs that were BrdU + after low MOI mCherryCre and mCherryonly lentiviral infection. N = 3/grp/exp, 3 exps. Mean ± SEM shown. f Representative images of cultured Vegfa lox/lox NSCs (brightfield) after lentiviral infection (mCherry + ) after 1 and 4 passages. Images taken immediately after passage, when counting was performed. g Representative images of cultured WT NSCs (brightfield) after lentiviral infection (mCherry + ) after 1 and 4 passages. Images taken immediately after passage, when counting was performed. h Percent of mCherry + Vegfa lox/lox and WT NSCs after infection with low MOI mCherryCre or mCherryonly lentiviral vectors. N = 3/grp/exp, 2 exps; mean ± SEM. Scale bars represent d 10 µm and f , g 50 µm. * p < 0.05; ** p < 0.01; **** p < 0.0001

    Article Snippet: The following day, after three rinses in PBS, cells were incubated in secondary antibodies diluted in blocking solution for 2 h. If a biotinylated secondary was used, a fluorophore-conjugated tertiary was applied for 1 h diluted in PBS before rinsing and nuclei counterstaining with Hoechst (10 min, 1:2000 in PBS) (Invitrogen).

    Techniques: Concentration Assay, Cell Culture, Infection